The invention relates to Rh, Ru, Co and Ir complexes comprising bidentate diphosphoramidites as ligands and to the use thereof as catalysts for the hydroformylation of olefins. The invention also relates to a process for preparing an aldehyde from an olefin using the complexes or ligands mentioned.

The present invention relates to disulfide masked prodrug compounds of Formula (I), nucleoside kinase bypass compositions thereof and methods that are amenable to bioactivation by a reducing agent such as glutathione: ##STR00001## Such disulfide based compounds, compositions, and methods can be useful, for example, in providing prodrugs for use as therapeutics.

Methods to access 2-aryl chromene compounds via an asymmetric catalytic process.

Provided herein are prodrug compounds, their preparation and their uses, such as treating liver diseases or nonliver diseases via intervening in molecular pathways in the liver. Novel prodrug compounds of acid/alcohol derivatives such as phosphates, phosphonates, phosphonamidates, phosphoramidates, carboxylates, phenolates, and alkoxylates, their preparation and their uses are described. Some of the novel prodrug compounds described herein do not generate a vinyl keto reactive intermediate in the activation process. Another aspect includes the use of prodrugs to treat diseases that benefit from enhanced drug distribution to the liver and like tissues and cells.

The invention relates to: a) phosphoramidites of formula (I); b) transition-metal-containing compounds of the formula Me(acac)(CO)L, wherein L is selected from formula (I); c) catalytically active compositions in hydroformylation that have the compounds mentioned under a) and b); d) a method for the hydroformylation of unsaturated compounds by using the catalytically active composition mentioned under c); and e) a multi-phase reaction mixture, containing unsaturated compounds, a gas mixture, which comprises carbon monoxide and hydrogen, aldehydes, and the catalytically active composition described under c).

A prodrug platform is useful to deliver pharmaceutically active amines, amides and phenols and their use in the diagnosis, prevention and/or treatment of various diseases. Compared with the parent drug (e.g., Gemcitabine), the prodrugs show a significant overall safety improvement (therapeutic index (TI) improvement), especially in liver. The prodrugs can treat several diseases, including, for example, cancer, metabolic disease, viral infection, immunological disease, neurologic disease, and blood disease.

Compounds containing polymer material and a phosphorous flame protection agent on the basis of an aminomethyl bisphosphonate, a method for manufacturing the compound, the use of the flame retardant, and selected structures of the flame retardant are disclosed.

A process for the hydrocyanation of an organic compound containing at least one olefinic group comprising reacting the organic compound with hydrogen cyanide in the presence of a catalyst complex comprising at least one transition metal and an organic ligand containing at least one PN linkage, wherein the P and N atoms of the PN linkage are cach bonded to two other atoms.